theophylline has been researched along with Growth Disorders in 3 studies
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Inhaled corticosteroids (ICS), because of their efficacy, remain a cornerstone in managing persistent pediatric asthma, but also are associated with significant adverse effects, including growth suppression." | 2.41 | Balancing safety and efficacy in pediatric asthma management. ( Skoner, DP, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinués, B | 1 |
| Fanlo, A | 1 |
| Vicente, J | 1 |
| Mayayo-Sinués, E | 1 |
| Mayayo, E | 1 |
| Labarta, JI | 1 |
| Ferrandez-Longás, A | 1 |
| Skoner, DP | 1 |
1 review available for theophylline and Growth Disorders
| Article | Year |
|---|---|
Balancing safety and efficacy in pediatric asthma management.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents | 2002 |
2 other studies available for theophylline and Growth Disorders
| Article | Year |
|---|---|
Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children.
Topics: Adolescent; Aryl Hydrocarbon Hydroxylases; Caffeine; Child; Child, Preschool; Chromatography, High P | 2008 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta | 2000 |